Usage of this drug is indicated in the treatment of hypertension, angina chronic or stable angina, supraventricular tachyarrhythmias, and rapid conversion to sinus rhythm.

Mild to moderate side effects have been observed. Side effects such as dizziness, fatigue, headache, nausea, noisy breathing, blurred vision, itching, rashes in some cases, tingling sensations, and vomiting.

This drug is to be prescribed cautiously in patients with low blood pressure, hypotension, severe dizziness, or unusual fatigue.

This drug is contraindicated in patients with a history of previous severe hypotension, second or third-degree heart block, sick sinus syndrome, left ventricular dysfunction, AV blockage, or Wolf Parkinson White syndrome.

In adults, the usual dosage for PSVT is 0.1-3 mg/kg to be administered intravenously over 2 minutes; a maximum of 5 mg/first dose can be given.

We have also established roots and begun this new venture in other countries as well, such as the Netherlands, Romania, Greece, Siberia, and Iran.

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai